Analysis of claims data showed reduced utilization and costs among patients with nonintensively managed type 2 diabetes using self-monitoring of blood glucose compared with continuous glucose monitoring.
Ian Duncan, PhD
Advertisement
Articles by Ian Duncan, PhD
Deploying vibration-controlled transient elastography/controlled attenuation parameter devices at the population level is a financially advantageous solution to address the epidemic of fatty liver disease.
Advertisement
Latest Updated Articles
Cost Analysis of Self-Monitoring Blood Glucose in Nonintensively Managed Type 2 DiabetesPublished: September 1st 2023 | Updated:
- Population-Based Return on Investment of Deploying Transient Elastography
Published: May 28th 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Withdrawal of Aid Could Cause Millions of Lives Lost to HIV
2
EASO Recommends Semaglutide, Tirzepatide for First-Line Obesity Therapy
3
Recent FDA Approvals Expand Dermatology Options for Patients With Skin of Color
4
Mortality Gap Between Puerto Rico and the US Mainland Among Medicare Advantage Enrollees
5
